fosinopril has been researched along with Hypertrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, H; Li, P; Liang, Q; Lu, J; Luo, G; Wang, Y; Yin, T; Zhang, H; Zhang, X; Zhao, T | 1 |
1 other study(ies) available for fosinopril and Hypertrophy
| Article | Year |
|---|---|
Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Fosinopril; Gas Chromatography-Mass Spectrometry; Humans; Hypertrophy; Kidney Cortex; Male; Metabolomics; Proteinuria; Rats; Rats, Wistar; Toxins, Biological | 2012 |